CAS ID: | 58001-44-8 |
Molecular Formula: | C8H9NO5 |
Molecular Weight: | 199.2 g/mol |
Monoisotopic Mass: | 199.0481 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | BRL 14151 | Clavulanic Acid | Clavulanate | BRL 14151K | CLAVULANATE POTASSIUM |
Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
PubMed ID | 22018680 | Target ID | |
Uniprot ID | Name | ||
Model | human | Fibrosis Disease | Cystic fibrosis |
Process I | |||
Process II | |||
Process III | |||
Mechanism |
Trial Record 1
ClinicalTrial ID | NCT00153634 | Disease | Cystic fibrosis |
Phase | Not Applicable | Status | Completed |
First Received | September 12, 2005 | Last Verified | March 13, 2008 |
Sponsor | Seattle Children's Hospital |